Qili Qiangxin Capsule Combined With Sacubitril/Valsartan for HFrEF: A Systematic Review and Meta-Analysis

Background: Heart failure with reduced ejection fraction (HFrEF) is a complex, chronic disease and is among the top causes of morbidity and mortality. Angiotensin receptor-neprilysin inhibitor drugs represented by sacubitril/valsartan are the key drugs for the treatment of HFrEF in western medicine,...

詳細記述

保存先:
書誌詳細
主要な著者: Qian Xiang (著者), Mengxi Wang (著者), Yuhan Ding (著者), Manlu Fan (著者), Huaqin Tong (著者), Jiandong Chen (著者), Peng Yu (著者), Le Shen (著者), Xiaohu Chen (著者)
フォーマット: 図書
出版事項: Frontiers Media S.A., 2022-04-01T00:00:00Z.
主題:
オンライン・アクセス:Connect to this object online.
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

インターネット

Connect to this object online.

3rd Floor Main Library

予約・返却請求 3rd Floor Main Library
請求記号: A1234.567
所蔵 1 利用可